Investors’ Patience Is Being Tested Right Now By Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Ironwood Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Ironwood Pharmaceuticals Inc is $701.26M. A total of 1.13 million shares were traded on the day, compared to an average of 1.95M shares.

In the most recent transaction, John Minardo sold 9,910 shares of IRWD for 4.27 per share on Aug 12 ’24. After the transaction, the Chief Legal Officer now owns 284,661 company shares. In a previous transaction on Aug 12 ’24, Silver Ronald sold 3,107 shares at 4.27 per share. IRWD shares that Principal Accounting Officer owns now total 158,370.

Among the insiders who bought shares, John Minardo acquired of 11,726 shares on Aug 12 ’24 at a per-share price of $4.05. In another insider transaction, McHugh Julie sold 22,766 shares at $6.29 per share on Jun 10 ’24. Company shares held by the Director now total 139,528.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IRWD has a high of $15.70 and a low of $3.79.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IRWD’s latest balance sheet shows that the firm has $620.13M in Cash & Short Term Investments as of fiscal 2021. There were $475.80M in debt and $161.70M in liabilities at the time. Its Book Value Per Share was -$2.01, while its Total Shareholder’s Equity was $605.91M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRWD is Buy with a score of 4.43.

Most Popular

Related Posts